Medicare has finalized its long overdue national coverage decision on CAR-T therapy, an innovative but expensive new cancer treatment that uses patients' immune cells to fight against the disease.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,